Home > Products > TG & TPO > Recombinant Anti-TG x Anti-TPO Bispecific Antibody (scIgG)

Recombinant Anti-TG x Anti-TPO Bispecific Antibody (scIgG)  (CAT#: SCIGG-189)

Recombinant Anti-TG x Anti-TPO Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-TG and anti-TPO IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two antigens simultaneously and block the synthesis of thyroid hormones. It is designed for the research of Autoimmune thyroid disease therapy.
Datasheet INQUIRY

Specifications

Targets
TG & TPO
Type
Single chain IgGs
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Autoimmune thyroid disease

Targets

Target 1
TG
Gene ID
UniProt ID
Alternative Names
AITD3, TG; thyroglobulin; TGN
Target 2
TPO
Gene ID
UniProt ID
Alternative Names
MSA; TPX; TDH2A; TPPO; thrombopoietin; megakaryocyte growth and development factor; MGDF
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "TG & TPO"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-TG x Anti-TPO Bispecific Antibody (scIgG) (SCIGG-189). Click the button below to contact us or submit your feedback about this product.